Cargando…

Pretreatment Thrombocytosis as a Prognostic Factor in Metastatic Breast Cancer

Background. An elevated platelet count is often associated with malignancies, and it has been confirmed as an adverse prognostic factor in various cancers including early stage breast cancer. We sought to determine if thrombocytosis is also a prognostic factor in metastatic breast cancer. Patients a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stravodimou, Athina, Voutsadakis, Ioannis A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707237/ https://www.ncbi.nlm.nih.gov/pubmed/23864954 http://dx.doi.org/10.1155/2013/289563

Ejemplares similares

Vinorelbine with or without Trastuzumab in Metastatic Breast Cancer: A Retrospective Single Institution Series
por: Stravodimou, Athina, et al.
Publicado: (2014)

Neurotrophic receptor tyrosine kinase family members in secretory and non-secretory breast carcinomas
por: Stravodimou, Athina, et al.
Publicado: (2022)

Thrombocytosis as a prognostic marker in stage III and IV serous ovarian cancer
por: Digklia, Antonia, et al.
Publicado: (2014)

Peroxisome Proliferator-Activated Receptor Gamma and Regulations by the Ubiquitin-Proteasome System in Pancreatic Cancer
por: Stravodimou, Athina, et al.
Publicado: (2012)

Prognostic Impact of Pretreatment Thrombocytosis in Epithelial Ovarian Cancer
por: Okunade, KS, et al.
Publicado: (2020)

The prognostic role of pretreatment thrombocytosis in gastric cancer: A systematic review and meta-analysis
por: Yang, Chen, et al.
Publicado: (2018)

Clinicopathological and prognostic significance of pretreatment thrombocytosis in patients with endometrial cancer: a meta-analysis
por: Bai, Yi-Yang, et al.
Publicado: (2019)

Pre-treatment platelet counts as a prognostic and predictive factor in stage II and III rectal adenocarcinoma
por: Steele, Morgan, et al.
Publicado: (2017)

Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer
por: Helgason, H H, et al.
Publicado: (2006)

Trastuzumab and Gemcitabine in Pretreated HER2 Overexpressing Metastatic Breast Cancer Patients: Retrospective Analysis of Our Series
por: Di Lauro, Vincenzo, et al.
Publicado: (2012)

Prognostic role of tumor budding in breast cancer
por: Voutsadakis, Ioannis A
Publicado: (2018)

Prognostic role of pretreatment thrombocytosis on survival in patients with cervical cancer: a systematic review and meta-analysis
por: Cao, Weijuan, et al.
Publicado: (2019)

Pretreatment thrombocytosis as an independent predictive factor for chemoresistance and poor survival in epithelial ovarian cancer
por: Nakao, Sari, et al.
Publicado: (2020)

Paraneoplastic Leukocytosis and Thrombocytosis as Prognostic Biomarkers in Non-small Cell Lung Cancer
por: BODDU, Prajwal, et al.
Publicado: (2016)

A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation
por: Calegari, M A, et al.
Publicado: (2017)

Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study
por: Awada, A, et al.
Publicado: (2008)

Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer
por: Murri, A M Al, et al.
Publicado: (2006)

Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines
por: Berruti, A, et al.
Publicado: (2005)

Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable
por: Vogl, U M, et al.
Publicado: (2006)

Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
por: Stemmler, H J, et al.
Publicado: (2011)

Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis
por: Ye, Qingjian, et al.
Publicado: (2018)

Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracy
por: Necchi, A, et al.
Publicado: (2014)

Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
por: Lobbezoo, D J A, et al.
Publicado: (2015)

Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients
por: Abajo, A, et al.
Publicado: (2010)

Landscape of BRIP1 molecular lesions in gastrointestinal cancers from published genomic studies
por: Voutsadakis, Ioannis A
Publicado: (2020)

Metastatic melanoma: prognostic factors and survival in patients with brain metastases
por: Frinton, E., et al.
Publicado: (2017)

Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial
por: Melichar, B, et al.
Publicado: (2011)

Prognostic Factors and Metastatic Patterns in Primary Myxoid/Round-Cell Liposarcoma
por: Haniball, J., et al.
Publicado: (2011)

Prognostic Factors and Recurrence in Breast Cancer: Experience at the National Cancer Institute of Mexico
por: Stankov, A., et al.
Publicado: (2012)

Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer
por: Batista, N, et al.
Publicado: (2004)

Evaluation of prognostic factors in liver-limited metastatic colorectal cancer: a preplanned analysis of the FIRE-1 trial
por: Giessen, C, et al.
Publicado: (2013)

Health state utilities for metastatic breast cancer
por: Lloyd, A, et al.
Publicado: (2006)

Pretreatment serum albumin-to-alkaline phosphatase ratio is an independent prognosticator of survival in patients with metastatic gastric cancer
por: Li, Yu-Ting, et al.
Publicado: (2022)

Expression of Neutral Endopeptidase, Endothelin-1, and Nuclear Factor Kappa B in Prostate Cancer: Interrelations and Associations with Prostate-Specific Antigen Recurrence after Radical Prostatectomy
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2012)

Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma
por: Abu-Zaid, Ahmed, et al.
Publicado: (2017)

Phase II multicentre study of docetaxel plus 5-fluorouracil in patients with anthracycline-pretreated metastatic breast cancer
por: Lortholary, A, et al.
Publicado: (2003)

The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy
por: Ku, J H, et al.
Publicado: (2015)

Thrombocytosis
por: Vitiritti, M
Publicado: (2010)

Prognostic Factors and Survival in Patients Treated Surgically for Recurrent Metastatic Uterine Leiomyosarcoma
por: Hoang, Han L. T., et al.
Publicado: (2014)

The association of pretreatment thrombocytosis with prognosis and clinicopathological significance in cervical cancer: a systematic review and meta-analysis
por: Cheng, Juan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b78nergovv5bn3db2u7fqqp155